Medicines the European Medicines Agency has recommended for use in the European Union on this topic.
Each number has its full source under its own list below.
10 medicines (authorised now). Newest first. Each links to its EMA page.
Active substance: ganirelix acetate
Active substance: follitropin delta
Active substance: follitropin alfa
Active substance: follitropin alfa
Active substance: follitropin alfa;lutropin alfa
Active substance: choriogonadotropin alfa
Active substance: lutropin alfa
Active substance: ganirelix
Active substance: follitropin beta
Active substance: follitropin alfa
Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.
Countries side by side on public measures for this topic.
Worldwide · 2024–2034
View report Healthcare ServicesWorldwide · 2024–2034
View report Healthcare ServicesWorldwide · 2024–2034
View report Healthcare ServicesWorldwide · 2024–2034
View report Healthcare ServicesWorldwide · 2024–2034
View report OTC & NutraceuticalsWorldwide · 2024–2034
View report
About 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income.
Read
Exploring PCOS challenges and innovations to improve diagnosis, treatment, and women’s health outcomes
ReadAcuitas market sizes and forecasts are only in our full reports. How we use public data.